Founding Date | 1892 |
GE Healthcare revenue breakdown by business segment: 88.5% from Healthcare Systems and 11.5% from Pharmaceutical Diagnostics
GE Healthcare revenue breakdown by geographic segment: 15.2% from China, 5.2% from Americas, 13.2% from Asia, 20.9% from Europe, 40.8% from U.S. and 4.7% from Other
Q1, 2019 | Q2, 2019 | Q3, 2019 | FY, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | FY, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | FY, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Backlog | $17.9 b | $18.2 b | $18.1 b | $18.5 b | $17.4 b | $17.2 b | $17.02 b | $17.1 b | $17.04 b | |||
Backlog (Equipment) | $6.6 b | $6.7 b | $6.7 b | $7 b | $6 b | $6.1 b | $5.48 b | $5.54 b | $5.56 b | |||
Backlog (Services) | $11.3 b | $11.5 b | $11.4 b | $11.5 b | $11.4 b | $11.1 b | $11.55 b | $11.56 b | $11.15 b | |||
Order Volume | $4.9 b | $5.2 b | $5.1 b | $21.2 b | $5.3 b | $4.2 b | $4.13 b | $18.65 b | $4.47 b | |||
Order Volume (Equipment) | $2.9 b | $3.2 b | $3.1 b | $13 b | $3.3 b | $2.4 b | $2.14 b | $10.81 b | $2.45 b | |||
Order Volume (Services) | $2 b | $2 b | $2.1 b | $8.2 b | $2 b | $1.8 b | $1.99 b | $7.84 b | $2.03 b | |||
Remaining Performance Obligations | $13 b | $14.25 b | $14.61 b | |||||||||
Remaining Performance Obligations (Equipment) | $3.66 b | $3.83 b | $4.23 b | |||||||||
Remaining Performance Obligations (Software and Services) | $9.34 b | $10.43 b | $10.38 b |